Antiphospholipid Syndrome in Renal Allograft Recipients-A Long-Term Multicenter Analysis.

Agnieszka Furmańczyk-ZawiskaBarbara Bułło-PionteckaMichał KomorniczakAlicja Dębska-ŚlizieńHanna Augustyniak-BartosikMagdalena Durlik

Published in: Journal of clinical medicine (2023)

Recipients with APS are at higher risk for allograft loss due to immune and non-immune causes. Renal allograft survival was inferior in recipients with APS and renal function remains impaired but stable.

Keyphrases

kidney transplantation
cross sectional
clinical trial